Skip to Content

MainStay Epoch US Equity Yield Investor EPLIX

Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 21.07  /  +0.32 %
  • Total Assets 1.0 Bil
  • Adj. Expense Ratio
    1.330%
  • Expense Ratio 1.330%
  • Distribution Fee Level High
  • Share Class Type Front Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 1.73%
  • Turnover 19%

USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 10:04 PM GMT+0

Morningstar’s Analysis EPLIX

Will EPLIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

MainStay Epoch US Equity Yield Investor's Average People Pillar and Process Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings EPLIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 21.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

JPMorgan Chase & Co

2.54 25.0 Mil
Financial Services

Broadcom Inc

2.46 24.2 Mil
Technology

Eli Lilly and Co

2.28 22.4 Mil
Healthcare

Bank of America Corp

2.22 21.8 Mil
Financial Services

MetLife Inc

2.14 21.1 Mil
Financial Services

AbbVie Inc

2.12 20.8 Mil
Healthcare

Merck & Co Inc

2.04 20.0 Mil
Healthcare

Cummins Inc

1.95 19.1 Mil
Industrials

UnitedHealth Group Inc

1.76 17.3 Mil
Healthcare

Johnson & Johnson

1.75 17.2 Mil
Healthcare